Published in Drug Law Weekly, June 15th, 2004
The patent protects an innovative computational method for the design of new drugs. Locus' proprietary core technology rapidly calculates the affinity of small molecule fragments, selected from Locus' proprietary fragment database, to allow accurate mapping of the surface of targeted proteins. From such information, Locus scientists identify viable drug binding sites and computationally design and synthesize new drug molecules for the target protein.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.